PE20081831A1 - Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona - Google Patents

Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona

Info

Publication number
PE20081831A1
PE20081831A1 PE2007001801A PE2007001801A PE20081831A1 PE 20081831 A1 PE20081831 A1 PE 20081831A1 PE 2007001801 A PE2007001801 A PE 2007001801A PE 2007001801 A PE2007001801 A PE 2007001801A PE 20081831 A1 PE20081831 A1 PE 20081831A1
Authority
PE
Peru
Prior art keywords
ketone
derivatives
alkyl
pyrrolidinil
piperidinil
Prior art date
Application number
PE2007001801A
Other languages
English (en)
Spanish (es)
Inventor
Pravin Iyer
Clara Jeou
Stephen M Lynch
Ann Marie Madera
Kerem Erol Ozboya
Robert James Weikert
Matthew C Lucas
Ryan Craig Schoenfeld
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39262542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081831(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20081831A1 publication Critical patent/PE20081831A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Seasonings (AREA)
PE2007001801A 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona PE20081831A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87596906P 2006-12-19 2006-12-19
US99956107P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
PE20081831A1 true PE20081831A1 (es) 2008-12-27

Family

ID=39262542

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2012000299A PE20121151A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
PE2007001801A PE20081831A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2012000299A PE20121151A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona

Country Status (30)

Country Link
US (2) US8084623B2 (OSRAM)
EP (3) EP2354124B1 (OSRAM)
JP (1) JP5394252B2 (OSRAM)
KR (1) KR101054189B1 (OSRAM)
CN (1) CN101563319B (OSRAM)
AR (1) AR064397A1 (OSRAM)
AT (1) ATE513808T1 (OSRAM)
BR (1) BRPI0720742B8 (OSRAM)
CA (1) CA2671378C (OSRAM)
CL (1) CL2007003672A1 (OSRAM)
CO (1) CO6190531A2 (OSRAM)
CR (1) CR10809A (OSRAM)
CY (1) CY1113916T1 (OSRAM)
DK (1) DK2354124T3 (OSRAM)
EC (1) ECSP099442A (OSRAM)
ES (2) ES2401129T3 (OSRAM)
HR (1) HRP20130362T1 (OSRAM)
IL (1) IL198879A0 (OSRAM)
MA (1) MA31142B1 (OSRAM)
MX (1) MX2009006334A (OSRAM)
MY (1) MY186650A (OSRAM)
NO (1) NO20092058L (OSRAM)
NZ (1) NZ577114A (OSRAM)
PE (2) PE20121151A1 (OSRAM)
PL (1) PL2354124T3 (OSRAM)
PT (1) PT2354124E (OSRAM)
RU (1) RU2479575C2 (OSRAM)
SG (1) SG170054A1 (OSRAM)
TW (1) TWI377202B (OSRAM)
WO (1) WO2008074703A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101977907A (zh) * 2008-03-20 2011-02-16 弗·哈夫曼-拉罗切有限公司 吡咯烷基衍生物及其用途
MX2010013447A (es) * 2008-06-18 2010-12-22 Hoffmann La Roche Aril-cetonas como inhibidores de reabsorcion de monoaminas.
CN102340992B (zh) * 2009-02-09 2014-11-05 桑诺维恩药品公司 吡咯烷三重再摄取抑制剂
JP5992192B2 (ja) * 2012-03-30 2016-09-14 三井金属鉱業株式会社 パラジウム触媒
KR20150013137A (ko) 2012-04-25 2015-02-04 에프. 호프만-라 로슈 아게 (3,4-다이클로로-페닐)-((s)-3-프로필-피롤리딘-3-일)-메탄온 하이드로클로라이드 및 제조 방법
TW201444798A (zh) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 作爲強效ｒｏｃｋ１及ｒｏｃｋ２抑制劑之苯基吡唑衍生物
WO2014134391A1 (en) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
CN110642880B (zh) * 2019-10-11 2021-12-31 长沙麓兴生物科技有限公司 一种氮未取代吡唑和吲唑类硼酸的制备方法
CN114014792B (zh) * 2021-12-15 2024-01-26 沈阳海诺威医药科技有限公司 一种7-(4-溴苯甲酰基)-1,3-二氢-2h-吲哚-2-酮的制备方法
IL314926A (en) 2022-02-28 2024-10-01 Noema Pharma Ag Triple uptake inhibitor for the treatment of atypical depression
CN116751157B (zh) * 2023-06-21 2025-09-12 上海再启生物技术有限公司 一种2-(2-氨基-5-溴-苯甲酰基)吡啶的放大制备方法
TW202525282A (zh) 2023-08-28 2025-07-01 瑞士商諾埃瑪製藥公司 使用三重再攝取抑制劑治療行為免疫-代謝叢集病症或疾病之方法
TW202515540A (zh) * 2023-08-30 2025-04-16 瑞士商諾埃瑪製藥公司 使用三重再攝取抑制劑治療睡眠障礙之方法
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
TW202535357A (zh) * 2024-01-05 2025-09-16 瑞士商諾埃瑪製藥公司 治療更年期及近更年期之方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073829A (en) * 1963-01-15 Certificate of correction
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
US3056795A (en) * 1958-04-30 1962-10-02 Sterling Drug Inc 3-aryl-3-(aroyl or alkanoyl)tropanes and preparation thereof
NL130088C (OSRAM) * 1960-03-14
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
GB2060937A (en) 1979-10-12 1981-05-07 Rolls Royce Fluid-flow restrictor assembly
ZA806501B (en) * 1979-10-27 1981-10-28 Richardson Merrell Inc 4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
CA1228867A (en) 1984-05-03 1987-11-03 G. Paull Torrence Methanol carbonylation process
CA2071897A1 (en) 1989-12-28 1991-06-29 Richard A. Glennon Sigma receptor ligands and the use thereof
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
FR2735127B1 (fr) 1995-06-09 1997-08-22 Pf Medicament Nouvelles piperazines heteroaromatiques utiles comme medicaments.
GB9523583D0 (en) * 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
FR2758327B1 (fr) 1997-01-15 1999-04-02 Pf Medicament Nouvelles arylpiperazines derivees de piperidine
KR100523184B1 (ko) * 1998-02-26 2005-10-24 악조 노벨 엔.브이. 아제티딘 및 피롤리딘의 유도체
AU6936500A (en) 1999-08-24 2001-03-19 Regents Of The University Of California, The Non-quinoline inhibitors of malaria parasites
US20020151712A1 (en) * 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
AU7315700A (en) * 1999-09-20 2001-04-24 Takeda Chemical Industries Ltd. Melanin concentrating hormone antagonist
CA2389049A1 (en) * 1999-09-27 2001-04-05 Georgetown University Dopamine transporter inhibitors and their use
WO2002022572A2 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US20040034019A1 (en) 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives
JP2006506346A (ja) 2002-09-03 2006-02-23 サイオス インク． ｐ３８キナーゼ阻害剤としてのインドール系誘導体
JP2006505531A (ja) 2002-09-11 2006-02-16 メルク　エンド　カムパニー　インコーポレーテッド メラノコルチン−４受容体作働薬としてのピペラジン尿素誘導体
US20050256159A1 (en) 2002-10-11 2005-11-17 Astrazeneca Ab 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
WO2004080925A2 (en) 2003-03-12 2004-09-23 The University Of Western Ontario Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes
US20060014987A1 (en) 2003-07-07 2006-01-19 Lan Huang Synthesis of beta-elemene, intermediates thereto, analogues and uses thereof
JP2005057154A (ja) * 2003-08-07 2005-03-03 Canon Inc 露光装置
CN1871222A (zh) 2003-10-24 2006-11-29 霍夫曼-拉罗奇有限公司 Ccr3受体拮抗剂
GB0325745D0 (en) 2003-11-05 2003-12-10 Astrazeneca Ab Chemical compounds
KR20050045927A (ko) 2003-11-12 2005-05-17 주식회사 엘지생명과학 멜라노코틴 수용체의 항진제
CA2557276A1 (en) 2004-02-26 2005-09-09 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic agent for neutrophilic inflammatory diseases
RU2382778C2 (ru) 2004-06-21 2010-02-27 Ф.Хоффманн-Ля Рош Аг Производные индола в качестве антагонистов гистаминовых рецепторов
NZ551799A (en) 2004-06-30 2009-11-27 Janssen Pharmaceutica Nv Phthalazine derivatives as PARP inhibitors
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
GT200500375A (es) * 2004-12-20 2006-11-28 Derivados de piperidina y su uso como agentes antiinflamatorios
DE102004061934A1 (de) 2004-12-22 2006-07-13 Siemens Ag Verfahren zur Datenübertragung zwischen einer sendenden und einer empfangenden Einheit in einem Bluetooth-Funkkommunikationssystem
AU2006209216A1 (en) 2005-01-25 2006-08-03 Galenea Corp Substituted arylamine compounds and their use as 5-HT6 modulators
WO2006086609A2 (en) 2005-02-10 2006-08-17 Axys Pharmaceuticals, Inc. Inhibitors of tryptase
WO2007068619A1 (en) 2005-12-12 2007-06-21 Nerviano Medical Sciences S.R.L. Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors
AU2007235578B2 (en) 2006-04-07 2011-07-14 Janssen Pharmaceutica N.V. Indoles and benzoimidazoles as modulators of the histamine H4 receptor

Also Published As

Publication number Publication date
TWI377202B (en) 2012-11-21
DK2354124T3 (da) 2013-03-11
MX2009006334A (es) 2009-06-23
CR10809A (es) 2009-06-25
EP2354124B1 (en) 2013-02-13
BRPI0720742B8 (pt) 2021-05-25
BRPI0720742A2 (pt) 2014-01-28
AU2007336375A1 (en) 2008-06-26
EP2102157A1 (en) 2009-09-23
RU2009122666A (ru) 2011-01-27
MA31142B1 (fr) 2010-02-01
EP2102157B1 (en) 2011-06-22
EP2684871A1 (en) 2014-01-15
US20080146607A1 (en) 2008-06-19
KR20090091194A (ko) 2009-08-26
MY186650A (en) 2021-08-03
CO6190531A2 (es) 2010-08-19
PE20121151A1 (es) 2012-08-27
ES2366980T3 (es) 2011-10-27
ES2401129T3 (es) 2013-04-17
NO20092058L (no) 2009-09-17
EP2684871B1 (en) 2016-05-04
AR064397A1 (es) 2009-04-01
NZ577114A (en) 2011-12-22
SG170054A1 (en) 2011-04-29
CA2671378C (en) 2015-10-20
CA2671378A1 (en) 2008-06-26
CY1113916T1 (el) 2016-07-27
US20120065225A1 (en) 2012-03-15
CN101563319A (zh) 2009-10-21
US8084623B2 (en) 2011-12-27
EP2354124A3 (en) 2011-09-14
HRP20130362T1 (en) 2013-05-31
ECSP099442A (es) 2009-07-31
WO2008074703A1 (en) 2008-06-26
CL2007003672A1 (es) 2008-07-25
JP5394252B2 (ja) 2014-01-22
US8513425B2 (en) 2013-08-20
TW200838859A (en) 2008-10-01
PL2354124T3 (pl) 2013-07-31
BRPI0720742B1 (pt) 2021-02-09
RU2479575C2 (ru) 2013-04-20
PT2354124E (pt) 2013-04-09
IL198879A0 (en) 2010-02-17
ATE513808T1 (de) 2011-07-15
KR101054189B1 (ko) 2011-08-03
EP2354124A2 (en) 2011-08-10
CN101563319B (zh) 2012-09-05
JP2010513379A (ja) 2010-04-30

Similar Documents

Publication Publication Date Title
PE20081831A1 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
PE20091724A1 (es) Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20170247A1 (es) Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1
PE20090890A1 (es) Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
JO2787B1 (en) Alternative amide derivatives and methods of use
ECSP088891A (es) Derivados bicíclicos como inhibidores de cetp
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
PE20110152A1 (es) Nuevos derivados de sulfamida sustituida
PE20090113A1 (es) Compuestos triciclicos como moduladores del receptor de glucocorticoides, composiciones y procedimientos
PE20070833A1 (es) Compuestos de pirimidinil benzotiofeno
EA201000280A1 (ru) Фармацевтические композиции, содержащие лиганды дофаминовых рецепторов, и способы лечения с помощью лигандов дофаминовых рецепторов
CO6270285A2 (es) Derivados de 4-[(4-amino-1, 3, 5-triazin-2-il)amino]-n-arilmetilcicloalquilcarboxamida
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20051054A1 (es) Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
BRPI0716069A2 (pt) composto, composiÇço farmacÊutica, e, mÉtodo para tratar um distérbio
PE20070491A1 (es) Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina
PE20091330A1 (es) Derivados de 4-aminopirimidina como antagonistas de receptores de histamina h4

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed